Fake Ozempic flooding black market
UK reports described fake Ozempic‑style products circulating on the black market, with users reporting severe adverse reactions after injecting cheap, unregulated versions. (abc.net.au) That coverage surfaced amid wider concerns about safety and the integrity of supply chains for GLP‑1 drugs. (abc.net.au)
Cheap, unregulated injections sold as Ozempic are circulating in the United Kingdom, and some users say they became violently ill after taking them. (abc.net.au) Australian Broadcasting Corporation reported on April 15, 2026 that television personality Aisleyne Horgan-Wallace bought a low-cost weight-loss injection through WhatsApp and later thought she was dying after using it. The report said British authorities now fear fake products are spreading through the black market. (abc.net.au) Ozempic is the brand name for semaglutide, a prescription drug made by Novo Nordisk, and it belongs to a class called glucagon-like peptide-1 receptor agonists, which mimic a gut hormone that helps control blood sugar and appetite. The World Health Organization said in June 2024 that falsified semaglutide had been detected in Brazil, the United Kingdom and the United States. (who.int) Britain’s Medicines and Healthcare products Regulatory Agency warned in October 2023 that fake pre-filled pens claiming to contain Ozempic or Saxenda had been found in the United Kingdom. The agency said some falsified Ozempic pens contained insulin, which can trigger dangerous low blood sugar if a person injects it by mistake. (gov.uk; gov.uk) The Medicines and Healthcare products Regulatory Agency said legitimate Ozempic and Saxenda supplied through licensed channels were not affected by those fake batches. Its advice was blunt: patients should not use pens they suspect are falsified and should report them through the Yellow Card safety system. (gov.uk; gov.uk) The World Health Organization said reports of falsified semaglutide products have increased across multiple regions since 2022. Its medical product alert covered three fake Ozempic batches identified in October 2023 in Brazil and the United Kingdom, and in December 2023 in the United States. (who.int) Novo Nordisk says high demand for these medicines has made counterfeiting a profitable criminal market. The company says it uses a “prevent, detect, and respond” strategy to track falsified products and report them to health authorities. (novonordisk.com) The immediate risk for buyers is simple: a fake pen may contain the wrong drug, the wrong dose, or something not sterile at all. That is why regulators in Britain and the World Health Organization keep steering patients back to licensed prescribers, pharmacies and official safety reporting systems. (gov.uk; who.int)
